United States · Seed startup

Who invested in Viage Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$10Mraised across 1 round since 2022, from 1 source

Latest round
Seed, $10MJan 2022
Investors
2
See who backed them

The rounds

  1. Jan 2022

Founders and team

From Viage Therapeutics's own website: 2 on the team.

  • Taka KodaPresident, Viage Therapeutics Japan
  • Neil SchwartzHead of R&D

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Viage Therapeutics

Who invested in Viage Therapeutics?

Viage Therapeutics's investors include ANRI and Kyoto University Innovation Capital Co., Ltd.

How much has Viage Therapeutics raised?

Viage Therapeutics has raised $10M across 1 round since 2022.

When did Viage Therapeutics last raise?

Viage Therapeutics's most recent round was a Seed of $10M in Jan 2022.

What was Viage Therapeutics's biggest round?

Its most recent round, $10M in Jan 2022, is also its largest on record.

Who backed Viage Therapeutics first?

Viage Therapeutics's first round on record, in Jan 2022, was backed by ANRI and Kyoto University Innovation Capital Co., Ltd.

What stage is Viage Therapeutics at?

Viage Therapeutics's latest named round is a Seed, in Jan 2022.

Where is Viage Therapeutics based?

Viage Therapeutics is based in the United States.

Companies like Viage Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.